ABVC BioPharma, Inc.
ABVC
Rank in Stocks
#25246
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on... ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Share Price
$0.9921
Last synced: 2026-11-11
Market Cap
$26.45M
Change (1 day)
0.21%
Change (1 year)
-66.82%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ABVC BioPharma, Inc. (ABVC)
Category
Healthcare
Operating Margin for ABVC BioPharma, Inc. (ABVC)
Operating Margin as of November 2026 TTM: 918.55%
According to ABVC BioPharma, Inc.'s latest financial reports, its current operating margin (TTM) is 918.55%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for ABVC BioPharma, Inc. from 2002 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 918.55% | 0.00% |
| 2025 | 0.00% | -100.00% |
| 2024 | -923.34% | -79.20% |
| 2023 | -4,439.24% | 184.83% |
| 2022 | -1,558.54% | -52.63% |
| 2021 | -3,290.07% | 86.84% |
| 2020 | -1,760.87% | 257.25% |
| 2019 | -492.90% | -98.77% |
| 2018 | -40,031.10% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | -100.00% |
| 2013 | -2,276.35% | -88.62% |
| 2012 | -20,004.31% | -66.20% |
| 2011 | -59,180.66% | 365.43% |
| 2010 | -12,715.16% | 0.00% |
| 2009 | 0.00% | -100.00% |
| 2008 | -21,340.32% | 101.39% |
| 2007 | -10,596.38% | 625.50% |
| 2006 | -1,460.56% | -17.29% |
| 2005 | -1,765.83% | -50,696.85% |
| 2004 | 3.49% | -102.00% |
| 2003 | -174.13% | -12.94% |
| 2002 | -200.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -99.96% |
US
|
|
| -149.01% | -100.16% |
US
|
|
| 25.57% | -99.97% |
AU
|
|
| 31.23% | -99.97% |
BE
|
|
| 29.35% | -99.97% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ABVC BioPharma, Inc.'s operating margin
What is ABVC BioPharma, Inc.'s operating margin?
ABVC BioPharma, Inc.'s operating margin is 918.55%, as of Nov 2026.
What was ABVC BioPharma, Inc.'s operating margin in 2025?
In 2025, ABVC BioPharma, Inc.'s operating margin was 0.00%, compared with -923.34% in 2024.
How has ABVC BioPharma, Inc.'s operating margin changed since 2020?
From 2020 to 2025, ABVC BioPharma, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2023 (-4,439.24%).
How does ABVC BioPharma, Inc.'s operating margin compare with similar companies?
ABVC BioPharma, Inc.'s operating margin (918.55%) is higher than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.